|

Assessment of AI Program 'DRISTi' as a Screening Tool

RECRUITINGSponsored by Artelus AI
Actively Recruiting
SponsorArtelus AI
Started2025-11-23
Est. completion2026-03
Eligibility
Age21 Years+
Healthy vol.Accepted
Locations2 sites

Summary

A study will be conducted to demonstrate that DRISTi will correctly diagnose Diabetic Retinopathy (e.g., mtmDR, PDR, DME) in eyes of patients with diabetes. Participants who have been diagnosed with diabetes mellitus and meet the other inclusion/exclusion criteria will be invited to participate and will consent to have ophthalmic images taken. These images will be analyzed by DRISTi AI software and evaluated by an ophthalmic reading center. The results will be compared, and a statistical analysis will be completed to ensure statistical significance in the outcomes thus proving DRISTi is an effective DR diagnosis tool.

Eligibility

Age: 21 Years+Healthy volunteers accepted
Inclusion Criteria:

1. Ability to sign and date the informed consent form
2. Stated willingness to comply with all study procedures and availability for the duration of the study
3. Age (≥)21 years of age or older
4. Diagnosed with diabetes mellitus as per criteria established by the World Health Organization (WHO) or the American Diabetes Association (ADA)

   1. Hemoglobin A1c (HbA1c) ≥ 6.5%
   2. Fasting Plasma Glucose (FPG) ≥ 126 mg/dL (7.0 mmol/L)
   3. Symptoms of hyperglycemia or hyperglycemic crisis with a random plasma glucose (RPG) ≥ 200 mg/dL (11.1 mmol/L)

Exclusion Criteria:

1. Persistent visual impairment in one or both eyes;
2. History of macular edema or retinal vascular (vein or artery) occlusion;
3. History of ocular injections, laser treatment of the retina, or intraocular surgery other than cataract surgery without complications;
4. Subject is contraindicated for fundus photography (for example, has light sensitivity);
5. Subject has contraindications for mydriatic medications or is unwilling or unable to dilate;
6. Subject is currently enrolled in an interventional study of an investigational device or drug for the same condition; or
7. Subject has a condition or is in a situation which in the opinion of the Investigator, might confound study results, may interfere significantly with the subject's participation in the study, or may result in ungradable clinical reference standard photographs
8. Subject falls into one of the below categories:

   * Adults unable to consent (individuals w/ impaired decision-making capacity)
   * Individuals who are not yet adults (infants, children, teenagers)
   * Pregnant women
   * Prisoners

Conditions2

DiabetesDiabetic Retinopathy (DR)

Locations2 sites

New Century Ophthalmology - Oxford
Oxford, North Carolina, 27565
Jeanne Champion, Site Coordinator Oxford9192347003Jeanne@ncophth.com
New Century Ophthalmology - Raleigh
Raleigh, North Carolina, 27617
Adriana Valencia, Site Coordinator Raleigh9192347406Adriana@ncophth.com

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.